Nutritional abnormalities and supplementation in chronic obstructive pulmonary disease

Clinics in Chest Medicine

Volumn 21, Issue 4, 2000, Pages 753-762

  Schols, A M W J ^a,b   Wouters, E F M ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; CYTOKINE; FATTY ACID; GROWTH FACTOR; HORMONE; HUMAN GROWTH HORMONE; NONSTEROID ANTIINFLAMMATORY AGENT;

CHRONIC OBSTRUCTIVE LUNG DISEASE; DIETARY INTAKE; ENERGY METABOLISM; EXERCISE; MORBIDITY; MORTALITY; MUSCLE ATROPHY; MUSCLE FUNCTION; NUTRITIONAL DISORDER; NUTRITIONAL SUPPORT; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; WEIGHT REDUCTION;

EID: 0034525067     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70182-9     Document Type: Article

References (72)

1. Gastric emptying, pulmonary function, gas exchange, and respiratory quotient after feeding a moderate versus high fat enteral formula meal in chronic obstructive pulmonary disease patients
2. Acute effects of inhaled salbutamol on the metabolic rate of normal subjects
3. Decreased mechanical efficiency in clinically stable patients with COPD
4. Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease
5. Breathing efficiency during inspiratory threshold loading in patients with chronic obstructive pulmonary disease
6. Total free living energy expenditure in patients with severe chronic obstructive pulmonary disease
7. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease
8. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A pro-spective, randomized, controlled study
9. The influence of an acute disease exacerbation on the metabolic and inflammatory profile in patients with COPD
10. Characterization of nonresponse to high-caloric oral nutritional therapy in depleted patients with COPD
11. Acute effects of nebulized salbutamol on resting energy expenditure in patients with chronic obstructive pulmonary disease and in healthy subjects
12. Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function
13. Elevated-TNF a production by peripheral blood monocytes of weight-losing COPD patients
14. Tumor necrosis factor-a levels and weight loss in chronic: Obstructive pulmonary disease
15. The effect of an aggresive support regimen on body composition in patients with severe COPD and weight loss
16. The effect of supplementary oral nutrition in poorly nourished patients with chronic obstructive pulmonary disease
17. Different patterns of chronic tissue wasting among emphysema and chronic bronchitis patients
18. Skeletal muscle weakness is predominantly the consequence of extremity fat-free mass wasting but not of airflow obstruction in patients with chronic obstructive pulmonary disease
19. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in outpatients with COPD
20. Nutritional support for individuals with COPD: A meta-analysis
21. A preliminary report on the effects of malnutrition on skeletal muscle composition in chronic obstructive pulmonary disease
22. The immune response to short-term nutritional intervention in advanced chronic obstructive pulmonary disease
23. Nitrogen and energy relationships in malnourished patients with emphysema
24. Tissue depletion in relation to physical function and quality of life in patients with severe COPD
25. Peripheral muscle weakness contributes to exercise limitation in COPD
26. Nutritional status and mortality in chronic obstructive pulmonary disease
27. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters
28. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders
29. Impaired glucose tolerance in patients with chronic hypoxic pulmonary disease
30. The daily energy expenditure in stable chronic obstructive pulmonary disease
31. The cost of breathing in stable chronic obstructive pulmonary disease
32. The nutritional status of patients with chronic obstructive pulmonary disease
33. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease
34. Oxygen cost of breathing in patients with emphysema or chronic bronchitis in acute respiratory failure
35. Dietary supplementation and respiratory muscle performance in patients with COPD
36. Prognostic value of nutritional status in chronic obstructive pulmonary disease
37. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD
38. The effect of oxygen with exercise on atrial natriuretic peptide in chronic obstructive lung disease
39. Expiratory flow limitation in COPD patients after single lung transplantation
40. Increased resting energy expenditure is related to plasma TNF-α concentration in stable COPD patients
41. Nutritional repletion in malnourished patients with emphysema
42. Nutritional state and exercise tolerance in patients with COPD
43. Effect of reduced body weight on muscle aerobic capacity in patients with COPD
44. The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease
45. Early nonelective readmission for chronic obstructive pulmonary disease is associated with weight loss
46. Plasma and muscle amino acid levels in relation to resting energy expenditure and inflammation in stable chronic obstructive pulmonary disease
47. Elevated iosine monophosphate levels in resting muscle of patients with stable COPD
48. Physiologic effects of oral supplemental feeding in malnourished patients with chronic obstructive pulmonary diseases, a randomized control study
49. Impact of nutritional support on functional status during an acute exacerbation of chronic obstructive pulmonary disease
50. TNF-α and hypermetabolism in COPD
51. Plasma leptin is related to pro-inflammatory status and dietary intake in patients with COPD
52. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease
53. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease
54. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial
55. Energy balance in chronic obstructive pulmonary disease
56. Transcutaneous oxygen saturation and carbon dioxide tension during meals in patients with chronic obstructive pulmonary disease
57. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation
58. Body composition and health-related quality of life in patients with obstructive airways disease
59. Resting energy expenditure and nutritional state of patients with increased oxygen cost of breathing due to emphysema, scoliosis and thoracoplasty
60. Growth hormone and pulmonary disease. Metabolic effects in patients receiving parenteral nutrition
61. Circulating leptin in patients with chronic obstructive pulmonary disease
62. Diaphragm and body weight in emphysema
63. Weight changes in the terminal stages of chronic obstructive pulmonary disease
64. Immediate postprandial effects of a nutritional supplement on symptoms and exercise capacity in patients with chronic obstructive pulmonary disease (COPD)
65. Effects of an acute exacerbation on nutritional and metabolic profile of patients with COPD
66. Acute exacerbations in patients with COPD: Predictors of need for mechanical ventilation
67. The effects of refeedling on peripheral and respiratory muscle function in malnourished chronic pulmonary disease patients
68. Nutritional intervention in malnourished patients with emphysema
69. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial
70. Modification of the thermogenic effect of acutely inhaled salbutamol by chronic inhalation in normal subjects
71. Metabolism and aerobic capacity of skeletal muscle in chronic respiratory failure related to chronic obstructive pulmonary disease